Dietary Lipids and Dyslipidemia in Chronic Kidney Disease

The progression of chronic kidney disease (CKD) leads to altered lipid metabolism. CKD patients exhibit high blood triglyceride (TG) levels, reduced concentrations and functionality of high-density lipoproteins (HDL), and elevated levels of atherogenic small, dense, low-density lipoproteins (sdLDL)....

Descripción completa

Detalles Bibliográficos
Autores principales: Kochan, Zdzislaw, Szupryczynska, Natalia, Malgorzewicz, Sylwia, Karbowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472557/
https://www.ncbi.nlm.nih.gov/pubmed/34579015
http://dx.doi.org/10.3390/nu13093138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472557/
https://www.ncbi.nlm.nih.gov/pubmed/34579015
http://dx.doi.org/10.3390/nu13093138

Ejemplares similares